Allogene Therapeutics, Inc.
US ˙ NasdaqGS ˙ US0197701065

SecurityALLO / Allogene Therapeutics, Inc.
InstitutionSquarepoint Ops LLC
Latest Disclosed Ownership116,379 shares
Latest Disclosed Value $ 283,965
Squarepoint Ops LLC reports 11.20% increase in ownership of ALLO / Allogene Therapeutics, Inc.

On May 15, 2026 - Squarepoint Ops LLC filed a 13F-HR form disclosing ownership of 116,379 shares of Allogene Therapeutics, Inc. (US:ALLO) valued at $283,965 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 104,656 shares of Allogene Therapeutics, Inc.. This represents a change in shares of 11.20% during the quarter. The current value of the position is $232,758 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F ALLOGENE THERAPEUTICS COM 019770106 116,379 11,723 11.20 284 97.90 0.0003
2026-02-13 2025-12-31 13F ALLOGENE THERAPEUTICS COM 019770106 104,656 -163,388 -60.96 143 -56.93 0.0002
2025-11-14 2025-09-30 13F ALLOGENE THERAPEUTICS COM 019770106 268,044 249,978 1,383.69 332 1,560.00 0.0003
2025-08-27 2025-06-30 13F/A-1 ALLOGENE THERAPEUTICS COM 019770106 18,066 -308,459 -94.47 20 -95.80 0.0000
2025-08-14 2025-06-30 13F ALLOGENE THERAPEUTICS COM 019770106 18,066 -308,459 20 0.0000
2025-08-27 2025-03-31 13F/A-1 ALLOGENE THERAPEUTICS COM 019770106 326,525 306,180 1,504.94 477 1,006.98 0.0006
2025-05-15 2025-03-31 13F ALLOGENE THERAPEUTICS COM 019770106 326,525 306,180 477 0.0006
2025-02-14 2024-12-31 13F ALLOGENE THERAPEUTICS COM 019770106 20,345 -168,152 -89.21 43 -91.84 0.0000
2024-11-14 2024-09-30 13F ALLOGENE THERAPEUTICS COM 019770106 188,497 61,869 48.86 528 78.64 0.0008
2024-08-14 2024-06-30 13F ALLOGENE THERAPEUTICS COM 019770106 126,628 126,628 295 0.0005
2024-02-14 2023-12-31 13F ALLOGENE THERAPEUTICS COM 019770106 0 -121,792 -100.00 0 -100.00
2023-11-14 2023-09-30 13F ALLOGENE THERAPEUTICS COM 019770106 121,792 71,855 143.89 386 55.65 0.0010
2023-08-14 2023-06-30 13F ALLOGENE THERAPEUTICS COM 019770106 49,937 -6,838 -12.04 248 -11.43 0.0008
2023-05-15 2023-03-31 13F ALLOGENE THERAPEUTICS COM 019770106 56,775 -143,589 -71.66 280 -77.78 0.0011
2023-02-14 2022-12-31 13F ALLOGENE THERAPEUTICS COM 019770106 200,364 -45,958 -18.66 1,260 -52.63 0.0050
2022-11-14 2022-09-30 13F ALLOGENE THERAPEUTICS COM 019770106 246,322 246,322 2,660 0.0134
2022-08-15 2022-06-30 13F ALLOGENE THERAPEUTICS COM 019770106 0 -269,320 -100.00 0 -100.00
2022-05-16 2022-03-31 13F ALLOGENE THERAPEUTICS COM 019770106 269,320 269,320 2,454 0.0105
2021-05-17 2021-03-31 13F ALLOGENE THERAPEUTICS COM 019770106 0 -15,792 -100.00 0 -100.00
2021-02-16 2020-12-31 13F ALLOGENE THERAPEUTICS COM 019770106 15,792 9,892 167.66 399 79.73 0.0030
2020-11-16 2020-09-30 13F ALLOGENE THERAPEUTICS COM 019770106 5,900 5,900 222 0.0030
2020-05-15 2020-03-31 13F ALLOGENE THERAPEUTICS COM 019770106 0 -54,596 -100.00 0 -100.00
2020-02-14 2019-12-31 13F ALLOGENE THERAPEUTICS COM 019770106 54,596 46,049 538.77 1,418 508.58 0.0084
2019-11-14 2019-09-30 13F ALLOGENE THERAPEUTICS COM 019770106 8,547 -1,854 -17.83 233 -16.49 0.0021
2019-08-14 2019-06-30 13F ALLOGENE THERAPEUTICS COM 019770106 10,401 -2,599 -19.99 279 -25.80 0.0027
2019-05-15 2019-03-31 13F ALLOGENE THERAPEUTICS COM 019770106 13,000 13,000 376 0.0040
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.